This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Mendaera’s robotic technology is compatible with Butterfly’s proprietary semiconductor-based ultrasound device and connected via Butterfly’s software development kit – Butterfly Garden – creating a system designed to improve precision and consistency for a broad range of image-guided, needle-based interventions.
11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).
Under the agreement, HeartFocus plans to integrate, and with subsequent agreements, release its patented, AI-powered software with Butterfly’s single-probe, whole-body handheld ultrasound system, subject to applicable approvals and authorizations.
The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. This webinar will delve into the key elements of an ideal system that can streamline processes, improve efficiency, and enhance patientcare.
milla1cf Wed, 06/05/2024 - 20:37 June 5, 2024 — UltraSight , a pioneer in digital health transforming cardiac imaging with artificial intelligence, is collaborating with Mayo Clinic on a new endeavor with the goal of enhancing cardiac care by harnessing the power of AI in point-of-careultrasound.
The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C. Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game changer as a clinician. F.A.C.C. “The Narula et al. Rinehart et al. JSCAI 2024.
Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. 2017;5:678-687. [5]
This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.
Our AI-enabled portfolio, including our Command Center Software Platform, Edison True PACS , and Venue Family ultrasound systems with Caption Guidance , is designed to directly address these issues. By integrating AI into our products, we enable clinicians to make better use of data, streamline their workflows, and enhance patientcare.
The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. This webinar will delve into the key elements of an ideal system that can streamline processes, improve efficiency, and enhance patientcare.
The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. This webinar will delve into the key elements of an ideal system that can streamline processes, improve efficiency, and enhance patientcare.
The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. This webinar will delve into the key elements of an ideal system that can streamline processes, improve efficiency, and enhance patientcare.
As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). The dynamic nature of these technologies necessitates ongoing education and training to harness their full potential.
The updated workflow indicates that direct imaging guidance, such as ultrasound, may be used as an alternative to fluoroscopy. "As 1 Among 208 patients included in the Real AF Registry cohort, a total of three PAEs were reported.1 observed among patients who underwent low fluoroscopy procedures and 0.3%
As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). The dynamic nature of these technologies necessitates ongoing education and training to harness their full potential.
Conavi ( www.conavi.com ) is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Conavi is an exciting commercial-stage company with groundbreaking technology and an accomplished management team. Mintz LLP is acting as legal counsel to Conavi.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 More information: www.acc.org If you enjoy this content, please share it with a colleague
Not only does this result in a cumbersome and inefficient workflow, as cardiologists must bounce between systems and locations to retrieve and compare relevant prior and current multi-modality information, it can also result in critical information gaps that have a direct, negative impact on patientcare and outcomes.
Electronic health record (EHR) software can significantly improve the quality of care and running a private practice. This technology is essential for any practice looking to maximize patientcare and save money. GEMMS ONE was built from insider knowledge, and it contains the features you need to improve your practice.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
milla1cf Wed, 04/03/2024 - 18:58 April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening. "The
One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patientcare and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.
Parikh, MD Analysis “Although this data demonstrates the value of real-world data in the assessments of new technologies in which randomized data are not always available, there is still work that needs to be done to evaluate the current utilization of advanced therapies for PE in underrepresented patient populations,” said Sahil A.
tim.hodson Tue, 04/15/2025 - 15:06 April 1, 2025 UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual Meeting 2025 of three abstracts highlighting promising study findings using its AI-driven ultrasound platform. Bird, MD, cardiologist at Mayo Clinic. Listen to the episode here.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
111 
Let's personalize your content